Eton Pharmaceuticals Inc
NASDAQ:ETON
Eton Pharmaceuticals Inc
Revenue
Eton Pharmaceuticals Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eton Pharmaceuticals Inc
NASDAQ:ETON
|
Revenue
$31.6m
|
CAGR 3-Years
825%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$81.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$58.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$61.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$34.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
See Also
What is Eton Pharmaceuticals Inc's Revenue?
Revenue
31.6m
USD
Based on the financial report for Dec 31, 2023, Eton Pharmaceuticals Inc's Revenue amounts to 31.6m USD.
What is Eton Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 3Y
825%
Over the last year, the Revenue growth was 49%. The average annual Revenue growth rates for Eton Pharmaceuticals Inc have been 825% over the past three years .